Data for: Favorable outcomes with tumor burden reduction following the administration of hypomethylating agents before allogeneic hematopoietic cell transplantation in patients with higher-risk myelodysplastic syndrome
Published: 03-05-2019| Version 1 | DOI: 10.17632/cn8n65v5gt.1
Contributors:
Description
This Excel file is the data of the patients we analyzed.